Page 50 – The Source | Washington University in St. Louis

Board of Trustees ad hoc committee on spring 2024 protests completes report

The ad hoc committee established by the WashU Board of Trustees to review the university’s policies and guidelines governing on-campus protests and demonstrations has completed its work.

Students

Wilmetta Toliver-Diallo

Wilmetta Toliver-Diallo never stops her work on behalf of students. When she is not helping students apply for competitive fellowships, she is lecturing in the Department of African and African American Studies. And when she is not mentoring Mellon Mays fellows, she’s co-hosting dinners for her neighbors on the South 40.

Public Health

Exposing ‘forever chemicals’: Rob Bilott brings his fight to WashU

Rob Bilott, the attorney who exposed DuPont’s water contamination cover-up, will speak April 7 for the Assembly Series. “Dark Waters,” a film based on his fight for justice, screens in advance.

Medicine

Researchers find missing link in autoimmune disorder

Scientists at WashU Medicine have identified a key component to launching immune activity and overactivity, providing a potential therapeutic target for autoimmune diseases.

Campus & Facilities

Learn about inspiring people at WashU

The Office of Human Resources has a new initiative to spotlight staff members doing amazing work and to help build connections among employees.

Students

03.17.25

Images from on and around the WashU campuses.

Campus & Facilities

WUSTL Key gets updated

The WUSTL Key will take on a different look Tuesday, March 18, as part of efforts to update WashU branding. Log-in details and access will remain the same.

Engineering

A closer look at biomolecular ‘Silly Putty’

Researchers at Washington University have developed a method to peer into biomolecular condensates, which could lead to a better understanding of condensate functions and their impairment in cancers and neurodegeneration.

Obituaries

William D. Owens, MD, professor emeritus of anesthesiology, 85

William D. Owens, MD, a highly regarded professor emeritus of anesthesiology and former head of the Department of Anesthesiology at Washington University School of Medicine, died of cancer Jan. 3.

Operations & Strategy

What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry

After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore — a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Olin Business School experts Patrick Aguilar and Peter Boumgarden.